Heparin-Induced Thrombocytopenia

Surgical Clinics of North America

Volumn 92, Issue 6, 2012, Pages 1559-1572

  Lanzarotti, Stephen ^a   Weigelt, John A ^b  

^a Evansville Surgical Associates   (United States)

^b MEDICAL COLLEGE OF WISCONSIN   (United States)

Author keywords

Direct thrombin inhibitor; Heparin induced thrombocytopenia; PF 4; Platelets; Thrombosis

Indexed keywords

ANCROD; ANTIVITAMIN K; ARGATROBAN; BLOOD CLOTTING FACTOR 10A INHIBITOR; DABIGATRAN ETEXILATE; DANAPAROID; DESULFATOHIRUDIN; FONDAPARINUX; HEPARIN; HIRULOG; IMMUNOGLOBULIN G ANTIBODY; LEPIRUDIN; PENTASACCHARIDE; THROMBIN INHIBITOR; THROMBOCYTE FACTOR 4; WARFARIN; XIMELAGATRAN;

ANTICOAGULANT THERAPY; ANTIGEN ANTIBODY COMPLEX; DIAPHORESIS; DRUG FEVER; DYSPNEA; HUMAN; IMMUNE RESPONSE; LABORATORY; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; REVIEW; SCREENING; SIDE EFFECT; TACHYCARDIA; THORAX PAIN; THROMBOCYTE; THROMBOCYTE COUNT; THROMBOCYTOPENIA; THROMBOSIS;

ANTICOAGULANTS; HEPARIN; HUMANS; THROMBOCYTOPENIA;

EID: 84869135313     PISSN: 00396109     EISSN: 15583171     Source Type: Journal    
DOI: 10.1016/j.suc.2012.08.015     Document Type: Review

References (33)

1. Warkentin T.E. History of heparin induced thrombocytopenia. Heparin induced thrombocytopenia 2004, 2-5. Marcel Dekker publisher, New York. 3rd edition. T.E. Warkentin, A. Greinacher (Eds.).
2. Rhodes G.R., Dixon R.H., Silver D. Heparin induced thrombocytopenia: eight cases with thrombotic-hemorrhagic complications. Ann Surg 1977, 186:752-758.
3. Hassan Y., Awaisu A., Aziz N.A., et al. Heparin-induced thrombocytopenia and advances in its therapy. J Clin Pharm Ther 2007, 32:535-544.
4. Pravinkumar E., Webster N.R. HIT/HITT and alternative anticoagulation: current concepts. Br J Anaesth 2003, 90:676-685.
5. Francis J.L., Palmer G.J., Moroose R., et al. Comparison of bovine and porcine heparin in heparin antibody formation after cardiac surgery. Ann Thorac Surg 2003, 75:17-22.
6. Safraz A., Iqbal O., Tobu M., et al. Immunobiology and pathophysiology of heparin induced thrombocytopenia/thrombosis syndrome-an update. Turk J Haematol 2002, 19(2):127-131.
7. Lo G.K., Sigouin C.S., Warkentin T.E. What is the potential for overdiagnosis of heparin induced thrombocytopenia?. Am J Hematol 2007, 82:1037-1043.
8. Lo G.K., Juhl D., Warkentin T.E. Evaluation of pretest clinical score (4 Ts) for the diagnosis of heparin induced thrombocytopenia in two clinical settings. J Thromb Haemost 2006, 4:759-765.
9. Greinacher A., Warkentin T.E. Treatment of heparin induced thrombocytopenia: an overview. Heparin induced thrombocytopenia 2004, 339. Marcel Dekker publisher, New York. 3rd edition. T.E. Warkentin, A. Greinacher (Eds.).
10. Warkentin T.E. Clinical picture of heparin induced thrombocytopenia in: heparin induced thrombocytopenia 2004, Marcel Dekker publisher, New York, p. 55-9. 3rd edition.
11. Greinacher A., Farner B., Kroll H., et al. Clinical features of heparin induced thrombocytopenia including risk factors for thrombosis: a retrospective analysis of 408 patients. Thromb Haemost 2005, 94:132-135.
12. Warkentin T.E., Kelton J.G. A 14 year study of heparin induced thrombocytopenia. Am J Med 1996, 101:502-507.
13. Warkentin T.E., Roberts R.S., Hirsch J., et al. Heparin induced skin lesions and other unusual sequelae of the heparin induced thrombocytopenia syndrome. Chest 2005, 127:1857-1861.
14. Warkentin T.E. Clinical presentations of heparin induced thrombocytopenia. Semin Hematol 1998, 35:9-16.
15. Aster R.H., Bougie D.W. Drug induced immune thrombocytopenia. N Engl J Med 2007, 357:580-587.
16. Hirsch J., Raschke R. Heparin and low molecular weight heparin: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest 2004, 126(Suppl):188S-203S.
17. Warkentin T.E., Levine M.N., Hirsch J., et al. Heparin induced thrombocytopenia in patients treated with low molecular weight heparin or unfractionated heparin. N Engl J Med 1995, 332:1330-1335.
18. Mureebe L., Graham J.A., Bush R.L., et al. Risk of heparin induced thrombocytopenia from heparin bonded vascular prostheses. Ann Vasc Surg 2007, 21:719-722.
19. Warkentin T.E. Platelet count monitoring and laboratory testing for heparin induced thrombocytopenia: recommendations of the College of American Pathologists. Arch Pathol Lab Med 2002, 126:1415-1423.
20. Selleng K., Warkentin T.E., Greinacher A. Heparin induced thrombocytopenia in intensive care patients. Crit Care Med 2007, 35:1165-1176.
21. Warkentin T.E., Heddle N.M. Laboratory diagnosis of immune heparin induced thrombocytopenia. Curr Hematol Rep 2003, 2:148-157.
22. Pouplard C., Gueret P., Fouassier M., et al. Prospective evaluation of the '4Ts' score and particle gel immunoassay specific to heparin/pf4 for the diagnosis of heparin induced thrombocytopenia. J Thromb Haemost 2007, 5:1373-1379.
23. Gruel Y., Regina S., Pouplard C. Usefulness of pretest clinical score (4Ts) combined with immunoassay for the diagnosis of heparin induced thrombocytopenia. Curr Opin Pulm Med 2008, 14(5):397-402.
24. Warkentin T.E., Sheppard J.I., Horsewood P., et al. Impact of the patient population on the risk for heparin induced thrombocytopenia. Blood 2000, 96(5):1703-1708.
25. Jang I.K., Hursting M.J. When heparins promote thrombosis. Circulation 2005, 111:2671-2683.
26. Warkentin T.E., Maurer B.T., Aster R.H. Heparin induced thrombocytopenia associated with fondaparinux. N Engl J Med 2007, 365:2653-2654.
27. Smythe M.A., Koerber J.M., Mattson J.C. The incidence of recognized heparin induced thrombocytopenia in a large, tertiary care teaching hospital. Chest 2007, 131:1644-1649.
28. Carrier M., Rodger M.A., Fergusson D., et al. Increased mortality in hemodialysis patients having specific antibodies to the platelet factor 4 complex. Kidney Int 2008, 73(2):213-219.
29. Guyatt G.H., Akl E.A., Crowther M., et al. Antithrombotic therapy and prevention of thrombosis, 9th edition: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest 2012, 141(Supp 2):26s-28s.
30. Warkentin T.E., Greinacher A., Koster A., et al. Treatment and prevention of heparin-induced thrombocytopenia; American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th edition). Chest 2008, 133(Suppl 6):340S-380S.
31. Lobo B., Finch C., Howard A., et al. Fondaparinux for the treatment of patients with acute heparin induced thrombocytopenia. Thromb Haemost 2008, 99:2-3.
32. Hassell K. The management of patients with heparin induced thrombocytopenia who require anticoagulant therapy. Chest 2005, 127(Suppl 2):1S-8S.
33. Di Nisio M., Middeldorp S., Buller H. Direct thrombin inhibitors. N Engl J Med 2005, 353:1028-1040.